ArticleThe Journal of urology2011

Gonadotropin-releasing hormone blockers and cardiovascular disease risk: analysis of prospective clinical trials of degarelix.

Matthew R Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.